ESC TV Today – Your Cardiovascular News
European Society of Cardiology
Subscribe
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter.
You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!
Available episodes
Newest first
Oldest first
22 hours ago
Episode 12: Among the topics: Primary prevention in the elderly – Acute and long-term treatment of pulmonary embolism
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
Primary prevention in the elderly
Acute and long-term treatment of pulmonary embolism
Diagnostics Made Easy – “Getting things right” with the continuity equation for aortic stenosis
Host: Susanna Price
Guests: Jane Armitage and Stephan Rosenkranz
Want to watch that episode? Go to: https://esc365.escardio.org/event/923
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Jane Armitage, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Victoria Delgado has declared to have potential conflicts of interest to report: speaker fees from Edwards Lifesciences, Medtronic, Novartis and Philips. Consulting fees from Edwards Lifesciences and Novo Nordisk.
Stephan Rosenkranz has declared to have potential conflicts of interest to report: speaker fees and consultation for Bayer, MSD, Boehringer-Ingelheim and Inari.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Mar 9, 2023
Episode 11: Among the topics: Artificial intelligence in cardiology - Hypertension and anti-hypertensive therapy in women
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
Artificial intelligence in cardiology – What to expect
Hypertension and anti-hypertensive therapy in women
Snapshots
Host: Susanna Price
Guests: Stephan Achenbach, Martin Cowie and Angela Maas
Want to watch that episode? Go to: https://esc365.escardio.org/event/907
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Angela Maas and Susanna Price have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Martin Cowie has declared to have potential conflicts of interest to report: employed by AstraZeneca as Clinical Vice President, Late Stage CVRM, Biopharmaceuticals R&D.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Feb 23, 2023
Episode 10: Among the topics: Tricuspid regurgitation - Cardiogenic shock
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Interventional aspects of cardiogenic shock
* Diagnosis and management of tricuspid regurgitation
* Statistics Made Easy: Type I and Type II errors and their significance
Host: Susanna Price
Guests: Rebecca Hahn, Nicolle Kraenkel and Holger Thiele
Want to watch that episode? Go to: https://esc365.escardio.org/event/898
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Holger Thiele have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Rebecca Hahn has declared to have potential conflicts of interest to report: Chief Scientific Officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored tricuspid valve trials, for which she receives no direct industry compensation.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Feb 9, 2023
Episode 9: Among the topics: Cardiac involvement in Fabry’s disease - Anti-thrombotic therapy post PCI: DAPT in 2023
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Cardiac involvement in Fabry’s Disease
* Anti-thrombotic therapy post PCI: DAPT in 2023
* Mythbusters: Powernap for heart health
Host: Rick Grobbee
Guests: Perry Elliott, Nicolle Kraenkel, Roxana Mehran and Franz Weidinger
Want to watch that episode? Go to: https://esc365.escardio.org/event/896
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Franz Weidinger have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Sanofi.
Roxana Mehran has declared to have potential conflicts of interest to report: institutional research payments from Abbott, Abiomed, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, Atricure, Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll;
personal fees from Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD; Equity <1% in Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF (no fee).
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Jan 26, 2023
Episode 8: Among the topics: Sudden Cardiac Death (SCD) in sports - In-flight medical emergencies
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Sudden Cardiac Death (SCD) in sports
* In-flight emergencies
* Diagnostics Made Easy – Identifying Brugada syndrome on the ECG
Host: Susanna Price
Guests: Carlos Aguiar, Nicolle Kraenkel, Thomas Schmitt and Sanjay Sharma
Want to watch that episode? Go to: https://esc365.escardio.org/event/837
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Sanjay Sharma have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Thomas Schmitt has declared to have potential conflicts of interest to report: employed by Deutsche Lufthansa AG / Lufthansa Group Business Services.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Jan 12, 2023
Episode 7: Among the topics: Hypertrophic cardiomyopathy - State of the art in bypass surgery
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Hypertrophic cardiomyopathy
* State of the art in bypass surgery
* Snapshots
Host: Susanna Price
Guests: Stephan Achenbach, Carlos Aguiar, Eugene Braunwald and Rafael Sadaba
Want to watch that episode? Go to: https://esc365.escardio.org/event/812
Disclaimer:
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Rafael Sadaba have declared that they have no potential conflicts of interest.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Eugene Braunwald has declared to have potential conflicts of interest to report: served on MyoKardia advisory committee.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Dec 22, 2022
ESC TV Today 2022 Year-end Special
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Selected highlight publications 2022
Host: Susanna Price
Guests: Stephan Achenbach, Carlos Aguiar, Davide Capodanno, Nicolle Kraenkel and Emma Svennberg
Want to watch that episode? Go to: https://esc365.escardio.org/event/844
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel and Susanna Price declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Emma Svennberg declared to have potential conflict of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Dec 8, 2022
Episode 6: Among the topics: The latest on Patent Foramen Ovale (PFO) closure - Spontaneous Coronary Artery Dissection (SCAD)
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* Update on indications and methods for Patent Foramen Ovale (PFO) closure
* Incidence, outcome, acute and chronic treatment of Spontaneous Coronary Artery Dissection (SCAD)
* Mythbusters: The earlobe crease
Host: Rick Grobbee
Guests: Carlos Aguiar, Lorenz Raeber and Jacqueline Saw
Want to watch that episode? Go to: https://esc365.escardio.org/event/802
Disclaimer:
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Jacqueline Saw declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Lorenz Raeber declared to have potential conflicts of interest to report: Consultation/speaker fees from Abbott, Amgen, AstraZeneca, Canon, Medtronic, Novo Nordisk, Occlutech, Sanofi. Research grants to the institution by Abbott, Biotronik, Heartflow, Sanofi, Regeneron.
Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
playlist_add
Nov 24, 2022
Episode 5: Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent studies
* The IRONMAN trial and the role of iron deficiency in heart failure
* New ESC Guidelines on cardiovascular management of patients undergoing non-cardiac surgery
* Statistics Made Easy: Part I
Host: Rick Grobbee
Guests: Sigrun Halvorsen, Paul Kalra and Emma Svennberg
Want to watch that episode? Go to: https://esc365.escardio.org/event/758
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Stephan Achenbach, Rick Grobbee, Sigrun Halvorsen and Nicolle Kraenkel declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Giuseppe Biondi-Zoccai declared to have potential conflicts of interest to report: Giuseppe Biondi-Zoccai has consulted for Balmed, Cardionovum, Crannmedical, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo.
Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Paul Kalra declared to have potential conflicts of interest to report: Research grants: Pharmacosmos. Consultancy and lectures honoraria: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Pharmacosmos, Servier, Vifor Pharma .
Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
playlist_add
Nov 10, 2022
Episode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
* Cardiology This Week: A concise summary of recent trials
* Highlights of the ESC Cardio Oncology Guidelines
* New Data in Renal Denervation: SYMPLICITY HTN-3
* Mythbusters: Coffee increases the risk for heart disease
Host: Rick Grobbee
Guests: Carlos Aguiar, Teresa Lopez Fernandez and Deepak Bhatt
Want to watch that episode? Go to: https://esc365.escardio.org/event/607
Disclaimer:
This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Teresa Lopez Fernandez declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Deepak Bhatt declared to have potential conflicts of interest to report: Research funding from Medtronic paid to Brigham and Women’s hospital for my role as co-Principal Investigator of SYMPLICITY HTN-3.
Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
playlist_add
Oct 27, 2022
Episode 3: Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode tackles:
* Cardiology this Week
* Factor XIa Inhibitors: A Breakthrough in Anticoagulation?
* Heart Failure Treatment: New Concepts for 2023 and Beyond
* Snapshots
Host: Susanna Price
Guests: Carlos Aguiar, Robert Storey, Carolyn Lam and Stephan Achenbach
Want to watch that episode? Go to: https://esc365.escardio.org/event/602
Disclaimer:
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Robert Storey declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Carolyn Lam declared to have potential conflict of interest to report: Carolyn S.P. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Actelion, Alleviant Medical, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai.
Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
playlist_add
Oct 13, 2022
Episode 2: Optimal Timing of Medication / Ventricular Arrhythmias and Sudden Death Prevention
This episode tackles:
* Cardiology this Week
* TIME - The Treatment in Morning versus Evening study
* ESC Guidelines on ventricular arrhythmias and the prevention of sudden cardiac death
* Diagnostics made easy
Host: Rick Grobbee
Guests: Carlos Aguiar, Ulrich Laufs, Emma Svennberg and Jacob Tfelt-Hansen
Want to watch that episode? Go to: https://esc365.escardio.org/event/601
playlist_add
Sep 29, 2022
Episode 1: The ADVOR Trial, plus the latest on TAVI durability
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode tackles:
* Cardiology this Week
* ADVOR Trial and contemporary diuretic treatment
* The latest on TAVI durability
* Mythbusters – Is eating eggs really bad for you?
Want to watch that episode? Go to: https://esc365.escardio.org/event/593
playlist_add
Sep 21, 2022
ESC TV Today - Your Cardiology News
Starting 29 September, watch it every other Thursday at 18:00 CEST (Paris time). Get updated, quickly, with ESC TV Today.
Tune in for 20 minutes, to get breaking news plus dynamic interviews and discussions on the hottest topics in cardiology.
playlist_add